Preblick Ryan has filed 8 insider transactions across 1 company since February 2026.
Most recent transaction: a option exercise of 6302 shares of Indivior Pharmaceuticals, Inc. ($INDV) on March 14, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 14, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Preblick Ryan | Chief Financial Officer | M | Common Stock | 6302 | $0.00 | 323,594.0000 | 125,000,000 | 1.99% | 0.01% |
| March 14, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Preblick Ryan | Chief Financial Officer | F | Common Stock | 2843 | $31.11 | 320,751.0000 | 125,000,000 | 0.88% | 0.00% |
| March 14, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Preblick Ryan | Chief Financial Officer | M | Restricted Stock Units | 6302 | $0.00 | 0.0000 | 125,000,000 | 100.00% | 0.01% |
| March 3, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Preblick Ryan | Chief Financial Officer | M | Performance Stock Units | 113510 | $0.00 | 0.0000 | 125,000,000 | 100.00% | 0.09% |
| March 3, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Preblick Ryan | Chief Financial Officer | F | Common Stock | 87597 | $31.98 | 230,343.0000 | 125,000,000 | 27.55% | 0.07% |
| March 3, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Preblick Ryan | Chief Financial Officer | M | Common Stock | 86949 | $0.00 | 317,292.0000 | 125,000,000 | 37.75% | 0.07% |
| Feb. 9, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Preblick Ryan | Chief Financial Officer | A | Performance Stock Units | 113510 | $0.00 | 113,510.0000 | 125,000,000 | 9999.99% | 0.09% |
| Feb. 10, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Preblick Ryan | Chief Financial Officer | A | Common Stock | 37358 | $0.00 | 317,940.0000 | 125,000,000 | 13.31% | 0.03% |